Announcement
23 Apr 2026
In April 2026, the United States government announced an agreement with Regeneron to implement most-favoured-nation drug pricing for American patients.
Source
Sign in to access
Number of interventions
3
0 certainly harmful
3 likely harmful
0 liberalising
List of interventions
Implementation date
No implementation date
Revocation date:
No revocation date
Announced: 23 Apr 2026
Local operations incentive
Recent update from 24 Apr 2026:
On 23 April 2026, the United States announced an agreement with Regeneron. According to Regeneron's press release, under the agreement, Regeneron will be free from Section 232 tariffs on its import...
Sign in to see more
Announced: 23 Apr 2026
Tax or social insurance relief
Recent update from 24 Apr 2026:
On 23 April 2026, the United States announced reaching an agreement with Regeneron. According to Regeneron's press release, the company will be free from Section 232 tariffs on its imported product...
Sign in to see more
Announced: 23 Apr 2026
Import tariff
Recent update from 24 Apr 2026:
On 23 April 2026, the United States announced an agreement with Regeneron under which the company agreed to implement most-favoured-nation pricing for its drugs and to make investments in U.S. manu...
Sign in to see more
Threads
See all
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70619
interventions
194
jurisdictions
United States: Drug Pricing Agreements
This Thread tracks the U.S. Administration’s agreements with pharmaceutical companies. It is based on the Executive Order titled “Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients.” These agreements include tariff relief measures for pharmaceutical companies in return for their commitments to implement most-favored-nation pricing for their drugs and to invest i...
Published: 11 Nov 2025
68
interventions
2
jurisdictions